These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 26026369)

  • 21. Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile.
    Gavaldà A; Miralpeix M; Ramos I; Otal R; Carreño C; Viñals M; Doménech T; Carcasona C; Reyes B; Vilella D; Gras J; Cortijo J; Morcillo E; Llenas J; Ryder H; Beleta J
    J Pharmacol Exp Ther; 2009 Nov; 331(2):740-51. PubMed ID: 19710368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of dual bronchodilation with QVA149 on cardiac safety in healthy volunteers.
    Drollmann A; Brown M; Sechaud R; Perry S; Hara H; Jones I; Febbraro S
    Int J Clin Pharmacol Ther; 2014 May; 52(5):369-80. PubMed ID: 24569129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacodynamic and pharmacokinetic profile of RBx 343E48F0: a novel, long acting muscarinic receptor antagonist.
    Gupta S; Malhotra S; Sinha S; Singh SK; Singh RK; Krishna S; Chhabra P; Chaira T; Kannayiram J; Sharma P; Aeron S; Kaur J; Kumar N; Sattigeri J; Shirumalla RK; Paliwal J; Dastidar SG; Cliffe IA; Ray A; Bhatnagar P
    Eur J Pharmacol; 2011 May; 658(2-3):219-28. PubMed ID: 21371471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of the classical Einthoven model of bronchoconstriction to the study of inhaled bronchodilators in rodents.
    McNamara A; Pulido-Rios MT; Hegde SS; Martin WJ
    J Pharmacol Toxicol Methods; 2011; 63(1):89-95. PubMed ID: 20594937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential for long-acting muscarinic antagonists in chronic obstructive pulmonary disease.
    Joos GF
    Expert Opin Investig Drugs; 2010 Feb; 19(2):257-64. PubMed ID: 20047505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Glycopyrronium bromide is a long-acting inhaled anticholinergic in the treatment of severe COPD].
    Ulrik CS
    Ugeskr Laeger; 2013 Aug; 175(35):1946-8. PubMed ID: 23978116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early protective effects of tiotropium bromide in patients with airways hyperresponsiveness.
    Terzano C; Petroianni A; Ricci A; D'Antoni L; Allegra L
    Eur Rev Med Pharmacol Sci; 2004; 8(6):259-64. PubMed ID: 15745385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged effect of tiotropium bromide on methacholine-induced bronchoconstriction in asthma.
    O'Connor BJ; Towse LJ; Barnes PJ
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):876-80. PubMed ID: 8887578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tiotropium bromide exerts anti-inflammatory activity in a cigarette smoke mouse model of COPD.
    Wollin L; Pieper MP
    Pulm Pharmacol Ther; 2010 Aug; 23(4):345-54. PubMed ID: 20362689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pooled safety analysis of the fixed-dose combination of indacaterol and glycopyrronium (QVA149), its monocomponents, and tiotropium versus placebo in COPD patients.
    Wedzicha JA; Dahl R; Buhl R; Schubert-Tennigkeit A; Chen H; D'Andrea P; Fogel R; Banerji D
    Respir Med; 2014 Oct; 108(10):1498-507. PubMed ID: 25135743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic characterization of GSK-961081 (TD-5959), a first-in-class inhaled bifunctional bronchodilator possessing muscarinic receptor antagonist and β2-adrenoceptor agonist properties.
    Hegde SS; Hughes AD; Chen Y; Steinfeld T; Jasper JR; Lee TW; McNamara A; Martin WJ; Pulido-Rios MT; Mammen M
    J Pharmacol Exp Ther; 2014 Oct; 351(1):190-9. PubMed ID: 25100753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease.
    Barnes PJ; Belvisi MG; Mak JC; Haddad EB; O'Connor B
    Life Sci; 1995; 56(11-12):853-9. PubMed ID: 10188785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhaled muscarinic antagonists for COPD--does an anti-inflammatory mechanism really play a role?
    Trevethick M; Clarke N; Strawbridge M; Yeadon M
    Curr Opin Pharmacol; 2009 Jun; 9(3):250-5. PubMed ID: 19286423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical properties, pharmacokinetics and pharmacological response of tiotropium in chronic obstructive pulmonary disease patients.
    Price D; Sharma A; Cerasoli F
    Expert Opin Drug Metab Toxicol; 2009 Apr; 5(4):417-24. PubMed ID: 19292598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease.
    Koumis T; Samuel S
    Clin Ther; 2005 Apr; 27(4):377-92. PubMed ID: 15922812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological analysis of the interaction of antimuscarinic drugs at M(2) and M(3) muscarinic receptors in vivo using the pithed rat assay.
    Armstrong SR; Briones S; Horger B; Richardson CL; Jaw-Tsai S; Hegde SS
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jan; 376(5):341-9. PubMed ID: 18064438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positive interaction of the novel beta2-agonist carmoterol and tiotropium bromide in the control of airway changes induced by different challenges in guinea-pigs.
    Rossoni G; Manfredi B; Razzetti R; Civelli M; Berti F
    Pulm Pharmacol Ther; 2007; 20(3):250-7. PubMed ID: 16533614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of Glycopyrronium Following Repeated Once-Daily Inhalation in Healthy Chinese Subjects.
    Sechaud R; Machineni S; Tillmann HC; Hara H; Tan X; Zhao R; Ren S; Hou J
    Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):723-731. PubMed ID: 26428357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of long-acting muscarinic antagonists on promoting ciliary function in airway epithelium.
    Katsumata M; Fujisawa T; Kamiya Y; Tanaka Y; Kamiya C; Inoue Y; Hozumi H; Karayama M; Suzuki Y; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Maekawa M; Setou M; Watanabe H; Ikegami K; Suda T
    BMC Pulm Med; 2022 May; 22(1):186. PubMed ID: 35527239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and tolerability of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patients.
    Vogelmeier C; Verkindre C; Cheung D; Galdiz JB; Güçlü SZ; Spangenthal S; Overend T; Henley M; Mizutani G; Zeldin RK
    Pulm Pharmacol Ther; 2010 Oct; 23(5):438-44. PubMed ID: 20416390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.